Style | Citing Format |
---|---|
MLA | Sepanlou SG, et al.. "Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study." PLoS ONE, vol. 12, no. 5, 2017, pp. -. |
APA | Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, Hakemi MS, Pourshams A, Khoshnia M, Gharravi A, Broumand B, Nobakhthaghighi A, Kalantarzadeh K, Malekzadeh R (2017). Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study. PLoS ONE, 12(5), -. |
Chicago | Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, Hakemi MS, et al.. "Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study." PLoS ONE 12, no. 5 (2017): -. |
Harvard | Sepanlou SG et al. (2017) 'Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study', PLoS ONE, 12(5), pp. -. |
Vancouver | Sepanlou SG, Barahimi H, Najafi I, Kamangar F, Poustchi H, Shakeri R, et al.. Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study. PLoS ONE. 2017;12(5):-. |
BibTex | @article{ author = {Sepanlou SG and Barahimi H and Najafi I and Kamangar F and Poustchi H and Shakeri R and Hakemi MS and Pourshams A and Khoshnia M and Gharravi A and Broumand B and Nobakhthaghighi A and Kalantarzadeh K and Malekzadeh R}, title = {Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study}, journal = {PLoS ONE}, volume = {12}, number = {5}, pages = {-}, year = {2017} } |
RIS | TY - JOUR AU - Sepanlou SG AU - Barahimi H AU - Najafi I AU - Kamangar F AU - Poustchi H AU - Shakeri R AU - Hakemi MS AU - Pourshams A AU - Khoshnia M AU - Gharravi A AU - Broumand B AU - Nobakhthaghighi A AU - Kalantarzadeh K AU - Malekzadeh R TI - Prevalence and Determinants of Chronic Kidney Disease in Northeast of Iran: Results of the Golestan Cohort Study JO - PLoS ONE VL - 12 IS - 5 SP - EP - PY - 2017 ER - |